Walpar Nutrition

Which are the latest news on Walpar Nutrition?

Why is Walpar Nutritions Ltd falling/rising?

As of 05-Sep, Walpar Nutritions Ltd's stock price is at 23.75, down 1.45%, and has significantly underperformed the Sensex, with a 1-week decline of 12.20% and a 1-month decline of 31.85%. The stock is trading below its moving averages and has seen an 80% drop in delivery volume, indicating a bearish trend and reduced investor interest.

As of 05-Sep, Walpar Nutritions Ltd's stock price is falling, currently at 23.75, which reflects a decrease of 0.35 or 1.45%. The stock has significantly underperformed compared to the benchmark Sensex, with a 1-week decline of 12.20% versus the Sensex's 1.15% drop, and a 1-month decline of 31.85% compared to the Sensex's 2.91% decline. Over the past year, the stock has decreased by 42.14%, while the Sensex has only fallen by 3.38%. <BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Investor participation has also declined, with delivery volume dropping by 80% compared to the 5-day average, suggesting reduced interest in the stock. Overall, these factors contribute to the ongoing decline in Walpar Nutritions Ltd's stock price.

Who are in the management team of Walpar Nutrition?

The management team of Walpar Nutrition includes Chairman & Managing Director Kalpesh Pravinchandra Ladhawala, along with several Executive Directors and Independent Directors, responsible for the company's strategic direction and management.

The management team of Walpar Nutrition includes the following individuals:<BR><BR>1. **Kalpesh Pravinchandra Ladhawala** - Chairman & Managing Director<BR>2. **Tanmaykumar Ashwinbhai Shah** - Whole-time Director<BR>3. **Sejal Ladhawala** - Executive Director<BR>4. **Abhishekkumar Dineshkumar Patel** - Executive Director<BR>5. **Fenil Prakashkumar Sha** - Executive Director<BR>6. **Jigneshkumar Dineshkumar Modi** - Executive Director<BR>7. **Krunal Jashubhai Patel** - Executive Director<BR>8. **Nidhi YogeshKumar Shah** - Executive Director<BR>9. **Divyanshu Subhashchandra Raval** - Executive Director<BR>10. **Jayshukh Ramjibhai Detroja** - Additional Non-Executive Director & Independent Director<BR>11. **Rupesh Himatla Shah** - Additional Non-Executive Director & Independent Director<BR>12. **Tapan Natverlal Patel** - Additional Non-Executive Director & Independent Director<BR>13. **Nehalkumar Jasvantlal Shah** - Additional Non-Executive Director & Independent Director<BR>14. **Priyanka Shah** - Company Secretary<BR>15. **Megha Shah** - Independent Director<BR><BR>This team is responsible for the strategic direction and management of the company.

What does Walpar Nutrition do?

Walpar Nutritions Ltd is a micro-cap company in the FMCG sector, originally established in 2009, with no recent sales or profit data reported. It has a market cap of INR 25 Cr, a P/E ratio of 10.00, and a debt-equity ratio of 0.63.

Overview:<BR>Walpar Nutritions Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is classified as a micro-cap company.<BR><BR>History:<BR>Walpar Nutritions Ltd was originally incorporated as a Partnership Firm named "M/s Walpar Healthcare" in 2009. The partnership underwent several changes in its constitution on March 9, 2015, August 15, 2017, and June 12, 2020. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 25 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 10.00<BR>Industry P/E: 44<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.63<BR>Return on Equity: 13.07%<BR>Price-to-Book: 1.34<BR><BR>Contact Details:<BR>Registrar Address: Not available<BR>Phone: N/A<BR>Email: N/A<BR>Website: N/A

Who are the peers of the Walpar Nutrition?

Walpar Nutrition's peers include Tapi Fruit, Jhandewala Foods, KMG Milk Food, and others. In terms of management risk, growth, and capital structure, Walpar Nutrition and Abram Food show good performance, while Tapi Fruit and others exhibit below-average ratings.

Peers: The peers of Walpar Nutrition are Tapi Fruit, Jhandewala Foods, KMG Milk Food, Lake Shore, Sinnar Bidi Udy., Abram Food, Kanco Tea, Tyroon Tea Co., and Novateor Resear.<BR><BR>Quality Snapshot: Good management risk is observed at Walpar Nutrition and Abram Food, while Average management risk is found at Abram Food, and Below Average management risk is noted at Tapi Fruit, Jhandewala Foods, Sinnar Bidi Udy., Kanco Tea, and Tyroon Tea Co. Growth is rated as Good for Walpar Nutrition and Abram Food, Average for Jhandewala Foods, and Below Average for Tapi Fruit, Sinnar Bidi Udy., Kanco Tea, and Tyroon Tea Co. Capital Structure is rated as Good for Tyroon Tea Co., Average for Abram Food, and Below Average for Tapi Fruit, Jhandewala Foods, Sinnar Bidi Udy., KMG Milk Food, Lake Shore, and Kanco Tea.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jhandewala Foods at 0.00%, while the lowest is Tapi Fruit at -44.51%. Walpar Nutrition's 1-year return is -41.86%, which is better than Tapi Fruit but worse than Jhandewala Foods. Additionally, Tapi Fruit and Kanco Tea have negative six-month returns.

How big is Walpar Nutrition?

As of 13th August, Walpar Nutrition Ltd has a market capitalization of 33.00 Cr, classifying it as a Micro Cap company, with no available financial data for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 16.56 Cr and Total Assets of 47.39 Cr.

As of 13th August, <BR><BR>Market Cap: Walpar Nutritions Ltd has a market capitalization of 33.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 16.56 Cr and Total Assets valued at 47.39 Cr.

Is Walpar Nutrition overvalued or undervalued?

As of November 17, 2025, Walpar Nutrition is considered very attractive and undervalued with a PE ratio of 24.64 and an EV to EBITDA of 14.13, making it a more appealing investment compared to peers like Hindustan Unilever and Nestle India, despite a year-to-date return of -12.18% against the Sensex's 10.02%.

As of 17 November 2025, the valuation grade for Walpar Nutrition has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company is currently assessed as undervalued. Key ratios include a PE ratio of 24.64, an EV to EBITDA of 14.13, and a PEG ratio of 0.47, which suggests that the stock is priced favorably relative to its growth prospects.<BR><BR>In comparison to its peers, Walpar Nutrition stands out with its lower valuation metrics; for instance, Hindustan Unilever has a PE ratio of 53.89 and an EV to EBITDA of 38.18, while Nestle India shows a PE of 81.88. This positions Walpar Nutrition as a more attractive investment opportunity within the FMCG sector. Despite recent underperformance against the Sensex, with a year-to-date return of -12.18% compared to the Sensex's 10.02%, the company's strong fundamentals and favorable valuation ratios suggest potential for future growth.

How has been the historical performance of Walpar Nutrition?

Walpar Nutrition has demonstrated significant growth from Mar'21 to Mar'25, with net sales increasing from 6.07 Cr to 71.76 Cr, and profit after tax rising from 0.15 Cr to 2.80 Cr, reflecting enhanced profitability and shareholder value. Total assets and liabilities have also grown proportionally, indicating a strong financial performance across various metrics.

Answer:<BR>The historical performance of Walpar Nutrition shows significant growth in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Walpar Nutrition's net sales have increased from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25, demonstrating a robust upward trend. The total operating income followed a similar trajectory, rising from 6.07 Cr in Mar'21 to 71.76 Cr in Mar'25. Raw material costs have also escalated, from 4.56 Cr in Mar'21 to 56.89 Cr in Mar'25, reflecting the company's expanding operations. Operating profit (PBDIT) has improved from 0.46 Cr in Mar'21 to 5.99 Cr in Mar'25, while profit before tax has surged from 0.16 Cr to 3.88 Cr during the same period. Profit after tax has risen from 0.15 Cr in Mar'21 to 2.80 Cr in Mar'25, indicating enhanced profitability. The earnings per share (EPS) have increased from 0.45 in Mar'21 to 2.47 in Mar'25, showcasing improved shareholder value. Total assets have grown from 17.97 Cr in Mar'21 to 47.39 Cr in Mar'25, while total liabilities increased from 17.97 Cr to 47.39 Cr, indicating a proportional growth in the company's financial structure. The cash flow from operating activities has remained positive, with a net cash inflow of 1.00 Cr in Mar'25 compared to previous years. Overall, Walpar Nutrition has shown a strong performance trajectory across various financial metrics over the years.

Who are the top shareholders of the Walpar Nutrition?

The top shareholders of Walpar Nutrition include Kalpesh Pravinchandra Ladhawala with 18.36%, individual investors with 22.58%, and Xtended Business Reporting Limited as the largest public shareholder at 2.22%. There are no mutual funds or foreign institutional investors involved.

The top shareholders of Walpar Nutrition are primarily the promoters, with Kalpesh Pravinchandra Ladhawala holding the largest share at 18.36%. In addition to him, individual investors collectively own 22.58% of the company. The highest public shareholder is Xtended Business Reporting Limited, which holds 2.22%. There are currently no mutual funds or foreign institutional investors holding shares in the company.

What is the technical trend for Walpar Nutrition?

As of June 4, 2025, Walpar Nutrition's trend is neutral with mixed signals, showing a shift from mildly bearish to sideways, as indicated by conflicting MACD readings and weak overall trend strength.

As of 4 June 2025, the technical trend for Walpar Nutrition has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating conflicting momentum. The RSI shows no signal on both weekly and monthly time frames, suggesting indecision. Daily moving averages are mildly bearish, contrasting with the weekly KST and Dow Theory, both of which are mildly bullish. The Bollinger Bands indicate a bullish trend on the weekly and a sideways trend on the monthly. Overall, the strength of the trend is weak, reflecting the sideways movement in price action and the lack of strong directional signals.

When is the next results date for Walpar Nutrition?

No Upcoming Board Meetings

What is the bonus history of the Walpar Nutrition?

Walpar Nutrition has announced a 1:1 bonus issue, with an ex-date and record date of August 14, 2024. Shareholders will receive one additional share for each share they own on that date.

Walpar Nutrition has announced a bonus issue with a ratio of 1:1. The ex-date for this bonus is set for August 14, 2024. This means that shareholders will receive one additional share for every share they currently own on that date. The record date for this bonus is also August 14, 2024. If you have any more questions about the company or its financial activities, feel free to ask!

Has Walpar Nutrition declared dividend?

No Dividend History Available